Covid vaccine: Nod for human trials marks beginning of end, says Centre

Covid vaccine: Nod for human trials marks beginning of end, says Centre Covid-19 vaccine candidate Covaxin, developed by the Hyderabad-based Bharat Biotech International Limited (BBIL) in collaboration with the ICMR and the National Institute of Virology (NIV), had recently got the nod for human clinical trials from the Drug Controller General of India (DCGI). https://ift.tt/eA8V8J